Hemolytic disease of the fetus and newborn in the sensitizing pregnancy where anti‐D was incorrectly identified as RhIG

• Published in: Journal of clinical laboratory analysis Vol. 36; no. 4; pp. e24323 - n/a
• Main Authors: Walhof, Mackenzie L., Leon, Judith, Greiner, Andrea L., Scott, James R., Knudson, Charles Michael
• Format: Journal Article
• Language: English
• Published: United States John Wiley & Sons, Inc 01.04.2022; John Wiley and Sons Inc
• Subjects: Agglutination; Anemia; Antibodies; Antigens; Blood banks; Case Report; Erythroblastosis, Fetal - diagnosis; Female; Fetus; Fetuses; HDFN; Hemolytic disease; Humans; Infant, Newborn; Medical records; Obstetrics; Patients; Polyethylene glycol; Pregnancy; Retrospective Studies; RhIG; Rho(D) Immune Globulin; transfusion; Ultrasonic imaging; Womens health; HDFN; RhIG; transfusion

Background Hemolytic disease of the fetus and newborn (HDFN) is a potentially fatal complication in Rh‐incompatible pregnancies and rarely occurs in the sensitizing pregnancy. Distinguishing RhIG from true anti‐D identified is challenging. A case of severe HDFN in which a sample drawn at 28 weeks sh...